The Effect of Cold Gel Pack Application on Itching in Burn Patients in the Maturation Stage

Launched by MARMARA UNIVERSITY · Mar 27, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how applying cold gel packs to burned areas can help reduce itching in patients whose wounds are healing. Itching can be a common and uncomfortable problem for burn patients, especially during the later stages of healing. Researchers believe that using cold gel packs may help lessen the severity of itching, making the healing process more comfortable.

To participate in this study, patients need to be over 18 years old and have burns covering 15-25% of their body that are healing (specifically, first or second-degree burns). They should also be able to describe their itching and have no other skin diseases besides the burns. Participants will apply cold gel packs to their burns and will be monitored to see if this helps reduce their itching compared to those who do not receive this treatment. It's important to note that certain medical conditions or medications may exclude someone from participating, so potential participants should discuss their health history with the study team.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Burn percentage is between 15-25% and 1st or 2nd degree burn areas are in the maturation phase (BatesJensen Wound Assessment Tool Scale score=1-13),
• • Describing itching in burn wounds in the last 24 hours,
• • Over 18 years of age,
• • Literate,
• • Oriented to person, place and time,
• • Having no vision, speech or communication problems,
• • Do not have any skin disease other than burns,
• • Patients whose vital signs are within physiological limits (Pulse: 60-100/min, Temperature: average 37 degrees Celsius, respiration 12-16/min, Blood Pressure: average 120/80).
• Exclusion Criteria:
• • Cold sensitivity/allergy,
• • Perineum, neck and inner wrist burn areas
• • Hypertrophic scar area,
• • Burn infection
• • Raynaud's disease,
• • Use of aspirin, anticoagulants, non-steriod anti-inflammatory drugs,
• • Evitamin and vasoactive agent use,
• • Peripheral vascular disease,
• • Connective tissue disease,
• • Diabetic neuropathy,
• • Use of a medication that will cause itching,
• • Patients participating in another study conducted at the clinic
• • Applying medical treatment in addition to the clinical routine due to itching,
• • Due to the fact that he was discharged in a shorter period of time than the average hospitalization day, the research process failure to complete,
• • Failure to comply with the monitoring process and conditions of the research,
• • It was determined as the person wanting to leave the study voluntarily.